Related Experiment Video
Updated: Jun 16, 2026

Equine Enteric Glial Culture and Application to the Study of a Neural Inflammatory Mechanism in Equine Colic
Published on: October 4, 2024
Neuronal responses to cytokines limit intestinal hypermotility and systemic effects of colonic inflammation
Jisun Jung1, Alec Wehmeier1, Zili Xie2
1Department of Internal Medicine, Division of Rheumatology, Washington University School of Medicine, St. Louis, MO, USA.
Abstract:
Inflammation results in increased gastrointestinal (GI) motility and diarrhea, but the mechanism remains unclear. Contrary to expectations, we found that neuronal responses to cytokine inhibited GI motility, as Nav1.8-Cre-mediated neuronal deletion of Jak1, a cytokine signaling intermediate, markedly increased GI motility at homeostasis. These cytokine-responsive neurons may reside in the enteric nervous system (ENS) based on the pattern of gene-deletion and GI motility induced by Nav1.8- and Trpv1-Cre. Cytokine receptors upstream of Jak1 that inhibit GI motility at homeostasis include IFNγ and IL-10, but not IL-4 or IFNα. While deficiency in cytokine inhibition of GI motility did not appear to affect the health of the mice at homeostasis, worse outcomes were observed after experimental Dextran sulfate sodium (DSS) colitis. Thus, we speculate that IFNγ and IL-10, cytokines associated with type 1 immune responses, may participate in a protective neuro-immune negative feedback loop to limit excessive GI motility during intestinal inflammation.
Related Concept Videos
Enteric Nervous System: Regulation of GI Motor Activity
During periods of fasting, the ENS initiates the migrating myoelectric complex, a program...
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Dysbiosis of the Gut Microbiota
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
